Professor Rupert Payne

About me:

Rupert Payne is a senior academic GP and clinical pharmacologist. He undertook his medical training and PhD in Edinburgh, and subsequently held a NIHR clinical lectureship in Cambridge and clinical senior lecturer position in Bristol.

He leads a programme of applied health service research focused on improving the safety and quality of medication use in primary care. He has a particular interest in improving how we measure, evaluate and manage polypharmacy, and has methodological expertise in pharmacoepidemiology, electronic health records, and data science. He is Deputy Director of the Exeter Collaboration for Academic Primary Care (APEx), where is also co-lead for impact. He also has responsibilities for clinical pharmacology and therapeutics teaching for Exeter's BMBS curriculum.

He practises clinically as a GP in North Somerset.

Interests:

Rupert leads a programme of applied health service research focused on improving the safety and quality of medicines use in primary care. He has worked with a wide range of quantitative and qualitative methodologies, and has particular expertise in pharmacoepidemiology, electronic health records, and data science.

Rupert has a particular interest in improving how we measure, evaluate and manage polypharmacy. He co-authored an influential King’s Fund report on this subject, and chaired the Research and Evidence section of the recent Department of Health National Overprescribing Review. He has led two major NIHR-funded clinical trials of medicines optimisation in general practice (IMPPP, BRISMED). Rupert is also currently developing a novel Inappropriate Polypharmacy Score to address limitations in current approaches to assessing polypharmacy.

Rupert recently led development of the Cambridge Multimorbidity Score, an increasingly widely used tool for quantifying multimorbidity using routine health records, as well as the Bristol Medication Review model, which outlines a flexible, patient-centred approach to structured medication review. He has also published on a range of other topics related to medications and health services, including deprescribing, pharmacovigilance, sustainability, continuity of care, multimorbidity, and cardiovascular disease.

Qualifications:

• MBChB (Edin)
• PhD (Edin)
• FRCGP
• FRCPE
• FBPhS
• FHEA